Tumour agnostic treatments in GI cancer

Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract cancer

Early treatment discontinuation and early oxaliplatin discontinuation for stage III colorectal cancer

HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients with uHCC

Comparing two chemo regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced oesophageal cancer

Nivo + chemo vs chemo as first-line treatment for advanced GC/GEJC/EAC